(Q44659372)

5 December 2017

title

Absence of reproductive and developmental toxicity in rats following oral dosing with nelfinavir (English)

1 reference

5 December 2017

1 reference

Leigh Ann Burns-Naas

1

1 reference

5 December 2017

Stephanie Webber

3

1 reference

5 December 2017

Lilit Masarjian

5

1 reference

5 December 2017

Grace Furman

6

1 reference

5 December 2017

Mark Zorbas

7

1 reference

5 December 2017

Donald G. Stump

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623481

3 April 2024

Joseph F. Holson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623481

3 April 2024

language of work or name

English

0 references

publication date

1 December 2003

1 reference

full work available at URL

5 December 2017

https://api.elsevier.com/content/article/PII:S0273230003000977?httpAccept=text/xml

1 reference

10.1016/S0273-2300(03)00097-7

DOI

https://api.crossref.org/works/10.1016/S0273-2300(03)00097-7

https://api.elsevier.com/content/article/PII:S0273230003000977?httpAccept=text/plain

3 April 2024

1 reference

10.1016/S0273-2300(03)00097-7

DOI

https://api.crossref.org/works/10.1016/S0273-2300(03)00097-7

Regulatory Toxicology and Pharmacology

3 April 2024

published in

1 reference

5 December 2017

volume

38

1 reference

5 December 2017

issue

3

1 reference

5 December 2017

page(s)

304-316

1 reference

Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2803%2900097-7

7 January 2021

Potential indicators of reproductive toxicity: testicular sperm production and epididymal sperm number, transit time, and motility in Fischer 344 rats

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2803%2900097-7

7 January 2021

Protease inhibitors and decreased birth weight in HIV-infected pregnant women with impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2803%2900097-7

7 January 2021

Risk of birth defects associated with nelfinavir exposure during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2803%2900097-7

7 January 2021

Combination antiretroviral therapy and duration of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2803%2900097-7

7 January 2021

Protease inhibitor treatment in HIV pregnant women. Is it safe for newborns?

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2803%2900097-7

7 January 2021

The evolving art of caring for pregnant women with HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2803%2900097-7

7 January 2021

Human immunodeficiency virus and pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2803%2900097-7

7 January 2021

Preputial separation as an external sign of pubertal development in the male rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2803%2900097-7

7 January 2021

Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2803%2900097-7

7 January 2021

Transplacental passage of protease inhibitors at delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2803%2900097-7

7 January 2021

Concentrations of protease inhibitors in cord blood after in utero exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2803%2900097-7

7 January 2021

Antiretroviral therapy in HIV-infected pregnant women and their infants: current interventions and challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2803%2900097-7

7 January 2021

Fresh visceral examination of rat and rabbit fetuses used in teratogenicity testing

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2803%2900097-7

7 January 2021

Antiretroviral therapy during pregnancy and the risk of an adverse outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2803%2900097-7

7 January 2021

10.1016/S0273-2300(03)00097-7

Identifiers

DOI

1 reference

5 December 2017

1 reference